Enrolling by invitationNot applicableNCT03755245

Biodistribution, Dosimetry and Performance of [68Ga]Ga-DOTA-Siglec-9 in Healthy and Patients With Rheumatoid Arthritis, Vasculitis or Pulmonary Sarcoidosis

Studying Sarcoidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Turku University Hospital
Principal Investigator
Anne Roivainen, Professor
Turku University Hospital, Turku PET Centre
Intervention
[68Ga]Ga-DOTA-Siglec-9(other)
Enrollment
26 enrolled
Eligibility
18-70 years · All sexes
Timeline
2018 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03755245 on ClinicalTrials.gov

Other trials for Sarcoidosis

Additional recruiting or active studies for the same condition.

See all trials for Sarcoidosis →

← Back to all trials